Characterization of subtype A HIV-1 from Africa by full genome sequencing - PubMed (original) (raw)
Characterization of subtype A HIV-1 from Africa by full genome sequencing
J K Carr et al. AIDS. 1999.
Abstract
Objective: To improve our understanding of the genetic complexity of HIV-1 subtype A by increasing the number of subtype A isolates that have been sequenced in their entirety.
Methods: Nine HIV-1-seropositive patients from Africa living in Sweden contributed peripheral blood mononuclear cells (PBMC) for this study. Sequencing of the C2-V3 region of env had shown them to be subtype A. DNA from virus cultures was used for the amplification of virtually full-length proviral sequences, and the resulting fragment was sequenced.
Results: Six of the nine viral isolates were subtype A throughout the genome, or non-recombinant, and all of these were from east Africa. One virus from the Ivory Coast had the AG(IbNG) genetic form, a recombinant form common in west Africa. Two of the isolates were novel recombinants: one was an A/C recombinant and the other was A/D. Analysis of gag reveals three subclusters within the A subtype: one containing the AG(IbNG) subtype viruses, one containing the AE(CM240) viruses and one containing the non-recombinant A viruses. These genetic clusters have different geographical distributions in Africa.
Conclusion: The prevailing view of HIV-1 subtype A forming a uniform band across the center of sub-Saharan Africa needs revision. In all probability, the most common subtype in west Africa and west central Africa is the AG recombinant, AG(IbNG), whereas in east central Africa it is the non-recombinant subtype A.
Similar articles
- Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG.
Montavon C, Toure-Kane C, Liegeois F, Mpoudi E, Bourgeois A, Vergne L, Perret JL, Boumah A, Saman E, Mboup S, Delaporte E, Peeters M. Montavon C, et al. J Acquir Immune Defic Syndr. 2000 Apr 15;23(5):363-74. doi: 10.1097/00126334-200004150-00001. J Acquir Immune Defic Syndr. 2000. PMID: 10866228 - Emerging recombinant human immunodeficiency viruses: uneven representation of the envelope V3 region.
Renjifo B, Gilbert P, Chaplin B, Vannberg F, Mwakagile D, Msamanga G, Hunter D, Fawzi W, Essex M. Renjifo B, et al. AIDS. 1999 Sep 10;13(13):1613-21. doi: 10.1097/00002030-199909100-00003. AIDS. 1999. PMID: 10509561 - The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon.
Carr JK, Torimiro JN, Wolfe ND, Eitel MN, Kim B, Sanders-Buell E, Jagodzinski LL, Gotte D, Burke DS, Birx DL, McCutchan FE. Carr JK, et al. Virology. 2001 Jul 20;286(1):168-81. doi: 10.1006/viro.2001.0976. Virology. 2001. PMID: 11448170 - Distribution of HIV-1 subtypes among HIV-seropositive patients in the interior of Côte d'Ivoire.
Nkengasong JN, Luo CC, Abouya L, Pieniazek D, Maurice C, Sassan-Morokro M, Ellenberger D, Hu DJ, Pau CP, Dobbs T, Respess R, Coulibaly D, Coulibaly IM, Wiktor SZ, Greenberg AE, Rayfield M. Nkengasong JN, et al. J Acquir Immune Defic Syndr. 2000 Apr 15;23(5):430-6. doi: 10.1097/00126334-200004150-00011. J Acquir Immune Defic Syndr. 2000. PMID: 10866237 - HIV subtype diversity worldwide.
Bbosa N, Kaleebu P, Ssemwanga D. Bbosa N, et al. Curr Opin HIV AIDS. 2019 May;14(3):153-160. doi: 10.1097/COH.0000000000000534. Curr Opin HIV AIDS. 2019. PMID: 30882484 Review.
Cited by
- Validation of Variant Assembly Using HAPHPIPE with Next-Generation Sequence Data from Viruses.
Gibson KM, Steiner MC, Rentia U, Bendall ML, Pérez-Losada M, Crandall KA. Gibson KM, et al. Viruses. 2020 Jul 14;12(7):758. doi: 10.3390/v12070758. Viruses. 2020. PMID: 32674515 Free PMC article. - Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden.
Neogi U, Siddik AB, Kalaghatgi P, Gisslén M, Bratt G, Marrone G, Sönnerborg A. Neogi U, et al. Sci Rep. 2017 Jul 25;7(1):6371. doi: 10.1038/s41598-017-06860-2. Sci Rep. 2017. PMID: 28744024 Free PMC article. - Comparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypes.
Grossman Z, Schapiro JM, Levy I, Elbirt D, Chowers M, Riesenberg K, Olstein-Pops K, Shahar E, Istomin V, Asher I, Gottessman BS, Shemer Y, Elinav H, Hassoun G, Rosenberg S, Averbuch D, Machleb-Guri K, Kra-Oz Z, Radian-Sade S, Rudich H, Ram D, Maayan S, Agmon-Levin N, Sthoeger Z. Grossman Z, et al. PLoS One. 2014 Jan 27;9(1):e86239. doi: 10.1371/journal.pone.0086239. eCollection 2014. PLoS One. 2014. PMID: 24475093 Free PMC article. - Acquisition of HIV by African-born residents of Victoria, Australia: insights from molecular epidemiology.
Lemoh C, Ryan CE, Sekawi Z, Hearps AC, Aleksic E, Chibo D, Grierson J, Baho S, Street A, Hellard M, Biggs BA, Crowe SM. Lemoh C, et al. PLoS One. 2013 Dec 31;8(12):e84008. doi: 10.1371/journal.pone.0084008. eCollection 2013. PLoS One. 2013. PMID: 24391866 Free PMC article. - Characterization of acute HIV-1 infection in high-risk Nigerian populations.
Charurat M, Nasidi A, Delaney K, Saidu A, Croxton T, Mondal P, Aliyu GG, Constantine N, Abimiku A, Carr JK, Vertefeuille J, Blattner W. Charurat M, et al. J Infect Dis. 2012 Apr 15;205(8):1239-47. doi: 10.1093/infdis/jis103. Epub 2012 Feb 21. J Infect Dis. 2012. PMID: 22357663 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous